DURHAM — The chief executive officer of Iqvia Holdings Inc. profited more than $13.5 million by exercising a stock option and selling the stock, according to a filing Wednesday with the Securities and Exchange Commission.

Ari Bousbib exercised his option to purchase 96,000 shares at a price of $21.36 per share on March 25, spending $2,050,560. He then sold all 96,000 shares at an average price of $140.96 per share.

IQVIA logo.

The profit was $13.53 million. Bousbib does not have another option to purchase shares at the $21.36 price.

The filing came just a month after Iqvia said in a filing his compensation fells $21.5M in 2018.

He still owns 730,137 shares worth more than $103 million.

Iqvia’s shares closed Wednesday at $141.15, down $2.51, or 1.75 percent.

Bousbib has been the CEO and chairman of Iqvia since October 2016. Before that, he served as the chief executive officer of IMS Health Holdings Inc. from September 2010 to October 2016.

The Durham-based company provides biopharmaceutical research analytics, which use data and science to help health care clients find better solutions for their patients.

Iqvia Holdings board member and his company sell $122 million of stock

Iqvia currently has approximately 58,000 employees in more than 100 countries.

The company’s approach to human data science is powered by the Iqvia Core, driving unique actionable insights at the intersection of big data, transformative technology and analytics with extensive domain expertise.

This story is from the North Carolina Business News Wire, a service of the UNC-Chapel Hill School of Media and Journalism

Iqvia’s genetics push includes patent for tech platform to access aggregated health data